OptiMedica’s (Stanford) Catalys Precision Laser System Study Published in Science Translational Medicine (11/17/2010)

OptiMedica is a medical device company focused in the area of cataract therapeutics. The company formerly developed and commercialized the PASCAL Method of retinal photocoagulation, which was developed at Stanford.

From the company’s press release:
Global ophthalmic device company OptiMedica Corp. has announced that results from a clinical study of its Catalys Precision Laser System were published in the peer-reviewed journal Science Translational Medicine (“Femtosecond Laser-Assisted Cataract Surgery with Integrated Optical Coherence Tomography,” Volume 2, Issue 58, November 17, 2010). The data showed that, when compared to manual techniques, the Catalys Precision Laser System helped surgeons achieve significant improvement in precision during several critical steps of cataract surgery. read full press release

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: